MedPath

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Not Applicable
Completed
Conditions
Melanoma, Uveal
Uveal Melanoma
Registration Number
NCT02874040
Lead Sponsor
Institut Curie
Brief Summary

Study the efficacy of endoresection of the tumor scar or, when surgery is not possible, transpupillary thermotherapy on the tumor scar to prevent neovascular glaucoma and secondary enucleation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
87
Inclusion Criteria
  • Tumor of 7 mm of thickness or more
  • Patients treated by proton beam therapy
  • Patients aged at least 18 years
  • Patients clearly informed of the study, having received the letter of information and signed the consent
Exclusion Criteria
  • Massive extrascleral extension posterior to the equator
  • Patients with metastasis at diagnosis.
  • Patients with glaucoma before the radiation therapy
  • Patients with opaque media preventing transpupillary thermotherapy
  • Patients for whom follow up will be difficult due to geographical, social or psychological reasons

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Post-treatment complication incidence.3 years

observed complications are : Number of glaucomas, numbrer of retinal detachment and number of secondary enucleations.

Secondary Outcome Measures
NameTimeMethod
Toxicity and side effects evaluation according to NCI-CTCAE v4.0 scale3 years
Measure of tumor scar thickness3 years

Trial Locations

Locations (1)

Institut Curie

🇫🇷

Paris, France

Institut Curie
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.